4//SEC Filing
Novara Mark David 4
Accession 0001438133-25-000229
CIK 0001438133other
Filed
Dec 16, 7:00 PM ET
Accepted
Dec 17, 4:02 PM ET
Size
8.9 KB
Accession
0001438133-25-000229
Insider Transaction Report
Form 4
Novara Mark David
EVP & CHIEF COMMERCIAL OFFICER
Transactions
- Exercise/Conversion
Common Stock
2025-12-15+7,415→ 39,799 total - Tax Payment
Common Stock
2025-12-15$22.11/sh−3,843$84,969→ 35,956 total - Exercise/Conversion
Restricted Stock Unit
2025-12-15−7,415→ 29,658 total→ Common Stock (7,415 underlying)
Footnotes (4)
- [F1]Shares withheld by Tandem Diabetes Care Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.
- [F2]Awarded on December 15, 2023 pursuant to the Tandem Diabetes Care Inc. 2023 Long-Term Incentive Plan, as amended, and agreements related thereto (the 2023 Plan).
- [F3]Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2023 Plan.
- [F4]RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 12/15/2024, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter.
Documents
Issuer
TANDEM DIABETES CARE INC
CIK 0001438133
Entity typeother
Related Parties
1- filerCIK 0002000342
Filing Metadata
- Form type
- 4
- Filed
- Dec 16, 7:00 PM ET
- Accepted
- Dec 17, 4:02 PM ET
- Size
- 8.9 KB